Alzheimer’s disease is the most commonly diagnosed form of dementia, but it’s far from the only one. In fact, most people who ...

New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...

Other noteworthy news in Alzheimer's disease this year included: News about Alzheimer's rose to the forefront in 2025, as the ...

Merck’s investigational antibody MK-2214 has received fast-track designation from the FDA for the treatment of Alzheimer’s disease. MK-2214 targets phosphorylated serine 413 tau (pS413), a marker of ...

The test confirms the scientific validity of the biomarkers used in the lab, led by researcher Carleara Weiss, and increases ...

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive degradation of brain cells, as well ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.

As Alzheimer’s Awareness Month comes to an end, Florida State University researchers are continuing efforts to better ...

Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and ...

Millions of people are living with Alzheimer's disease, a progressive, irreversible brain disorder that causes cognitive decline, confusion, memory loss, and many other symptoms. The Alzheimer's Assoc ...

Thousands of people have it, and thousands more are impacted by it. We're talking about Alzheimer's disease. But there's hope ...